Description: Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine program is BWV-101, an influenza vaccine. It also develops BWV-201, streptococcus pneumoniae vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was founded in 2018 and is based in Cincinnati, Ohio.
Home Page: www.bluewatervaccines.com
BWV Technical Analysis
201 East Fifth Street
Cincinnati,
OH
45202
United States
Phone:
513 620 4101
Officers
| Name | Title |
|---|---|
| Mr. Joseph Hernandez M.S., MBA | CEO, Pres & Exec. Chairman |
| Ms. Erin Henderson | Chief Bus. Officer & Corp. Sec. |
| Mr. Jon M. Garfield | Chief Financial Officer |
| Dr. Brian Price Ph.D. | Head of Technology Strategy |
| Dr. Ronald R. Cobb Ph.D. | Head of Science & Discovery |
| Mr. Andrew D. Skibo Ph.D. | Global Head of Biologics Operations |
| Mr. Theodore Scott Yoho | Head of Bus. Devel. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7157 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2022-02-18 |
| Fiscal Year End: | December |
| Full Time Employees: | 5 |